| A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine (NCT05652543) | Sinocelltech Ltd. | 2023-01-05 |
| Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG) (NCT05630209) | InSightec | 2023-01-04 |
| AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD) (NCT05693142) | REGENXBIO Inc. | 2023-01-04 |
| Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults (NCT05252845) | University of Oxford | 2023-01-04 |
| Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients (NCT05463224) | Sehhoon Park | 2023-01-04 |
| Gene Therapy for Adenosine Deaminase Severe Combined Immune Deficiency Using Peripheral Blood and EFS ADA Vector (NCT05432310) | University of California, Los Angeles | 2023-01-04 |
| A Long-term Extension Study to Evaluate Safety, Tolerability, and Efficacy of AL002 in Alzheimer's Disease (NCT05744401) | Alector Inc. | 2023-01-04 |
| Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPG (NCT05615623) | InSightec | 2023-01-04 |
| A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors (NCT05592626) | Marengo Therapeutics, Inc. | 2023-01-04 |
| Evaluate the Efficacy and Safety of FB2001 for Inhalation in Patients With Mild to Moderate COVID-19 (NCT05675072) | Frontier Biotechnologies Inc. | 2023-01-04 |
| SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease (NCT06155604) | The University of Hong Kong | 2023-01-04 |
| Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids (NCT05588323) | Shionogi | 2023-01-04 |
| Anti-PD-1 Re-challenge After Immune Priming by Ipilimumab and Immune Boosting by Radiotherapy in Advanced NSCLC (NCT05401786) | The Netherlands Cancer Institute | 2023-01-03 |
| Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets (NCT05637541) | Fujian Akeylink Biotechnology Co., Ltd. | 2023-01-03 |
| Glenzocimab for REperfusion in the Setting of Endovascular Therapy for Brain infarctioN: GREEN Study (NCT05559398) | Assistance Publique - Hôpitaux de Paris | 2023-01-03 |
| Different Doses of Naronapride vs. Placebo in Gastroparesis (NCT05621811) | Dr. Falk Pharma GmbH | 2023-01-03 |
| Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma (NCT05955157) | University of Malaya | 2023-01-03 |
| Live Double Combined Lactobacillus Capsule for Vaginal Use(IIb) (NCT07418918) | Guangdong Longchuangji Pharmaceutical Co., Ltd. | 2023-01-03 |
| Effect of Huaier Granule on Nephrotoxicity Associated With Targeted Therapy for Advanced Hepatobiliary Malignancies. (NCT05673824) | Fudan University | 2023-01-03 |
| Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections (NCT05472779) | Stephanie Wang Zuo | 2023-01-03 |
| Relmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell Lymphoma (NCT05590221) | Peking University Cancer Hospital & Institute | 2023-01-03 |
| Cannabidiol for the Treatment of Pelvic Pain in Endometriosis (DREAMLAND) (NCT05670353) | University of Sao Paulo | 2023-01-03 |
| A Phase II Stydy of Bevacizumab Plus Erlotinib in Patients for Krebs Cycle Altered Cancer (NCT05904457) | Asan Medical Center | 2023-01-02 |
| ADX-629 Therapy for Sjogren-Larsson Syndrome (NCT05443685) | University of Nebraska | 2023-01-02 |
| Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study (NCT03315832) | University Hospital, Limoges | 2023-01-02 |
| Anakinra in Dengue With Hyperinflammation ( AnaDen ) (NCT05611710) | Oxford University Clinical Research Unit, Vietnam | 2023-01-02 |
| Perioperative Propranolol During Prostatectomy to Decrease Cancer Recurrence (NCT05679193) | Oslo University Hospital | 2023-01-02 |
| Sleep Management And Recovery After Traumatic Brain Injury in Kids: Pilot Intervention of Melatonin (NCT04932096) | Oregon Health and Science University | 2023-01-02 |
| Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Early Breast Cancer (NCT05306041) | GBG Forschungs GmbH | 2023-01-02 |
| Phase 2b Study of GSK4532990 in Adults With NASH (NCT05583344) | GlaxoSmithKline | 2023-01-02 |
| Aumolertinib Combined Intrathecal Chemotherapy for Leptomeningeal Metastasis From EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles (NCT05810350) | Three Gorges Hospital of Chongqing University | 2023-01-01 |
| Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric Cancer (NCT05975749) | Fudan University | 2023-01-01 |
| EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control. (NCT03845751) | Institut Mutualiste Montsouris | 2023-01-01 |
| Establishment and Validation of Prediction Model of Simultaneous Chemoradiotherapy for Cervical Cancer Organoids (NCT06786780) | Chongqing University Cancer Hospital | 2023-01-01 |
| Postoperative Management for HNSCC Based on Pathological Response of Induction Chemotherapy and Immunotherapy (NCT05777824) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2023-01-01 |
| Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease (NCT04936854) | Haukeland University Hospital | 2023-01-01 |
| Cadonilimab (AK104) With or Without CT as 2rd Line Treatment for ES-SCLC (NCT05901584) | Second Affiliated Hospital of Zunyi Medical University | 2023-01-01 |
| The Efficacy of Incobotulinum Toxin A Injections for Treatment of Tinnitus: a Randomized Controlled Trial (NCT05650645) | University of Minnesota | 2023-01-01 |
| Study to Evaluate the Efficacy and Safety of Tenalisib, Given With CHOP Therapy for Front Line Treatment in Patients With PTCL (NCT05239910) | Rhizen Pharmaceuticals SA | 2023-01-01 |
| Zandelisib + Tazemetostat in R/R Follicular Lymphoma (NCT05604417) | Jacob Soumerai, MD | 2023-01-01 |
| FASTing-like Approach and Maintenance IMMunotherapy in ES-SCLC Patients Not Progressing on Chemoimmunotherapy Induction (NCT05703997) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2023-01-01 |
| Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma (NCT06527495) | Assiut University | 2023-01-01 |
| Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RP7214 in Combination With Azacitidine in Patients With Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia (NCT05246384) | Rhizen Pharmaceuticals SA | 2023-01-01 |
| PFNA vs Dual Mobility in Treatment of Unstable Trochanteric Fractures (NCT05677191) | Cairo University | 2023-01-01 |
| Trastuzumab, Bevacizumab with Paclitaxel for HER2-positive Gastric Cancer in a Second-line Therapy (NCT05640830) | Kangbuk Samsung Hospital | 2023-01-01 |
| Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma (NCT05978193) | Shanghai Chest Hospital | 2023-01-01 |
| DualStim Therapy With or Without Umbilical Cord Derived Wharton's Jelly for Erectile Dysfunction (NCT04424394) | BioIntegrate | 2023-01-01 |
| The Effect of LSD on Neural Synchrony, Prosocial Behavior, and Relationship Quality (NCT05670184) | Maastricht University | 2023-01-01 |
| Evaluate PU-AD in Subjects With Amyotrophic Lateral Sclerosis (NCT04505358) | Samus Therapeutics, Inc. | 2023-01-01 |
| Alternating Treatment With Fruquintinib and Bevacizumab Plus Capecitabine as Maintenance Therapy After First-Line Treatment in Metastatic Colorectal Cancer (NCT05659290) | Nanfang Hospital, Southern Medical University | 2023-01-01 |
| Neoadjuvant Long-course Chemoradiotherapy Followed by Immunotherapy for Locally Advanced Mid-low Rectal Cancer (NCT06493240) | Peking University People's Hospital | 2023-01-01 |
| UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases (NCT05535413) | Hunan Cancer Hospital | 2023-01-01 |
| Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks (NCT05557279) | Loyola University | 2023-01-01 |
| Effects and Mechanisms of Celecoxib on Intracerebral Hemorrhage (NCT05434065) | National Taiwan University Hospital | 2023-01-01 |
| Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease (NCT05611372) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-01-01 |
| Additive Effects of Intra-arterial Tenecteplase for Successful Thrombectomy Due to Acute Basilar Artery Occlusion (NCT05580822) | First Hospital of China Medical University | 2023-01-01 |
| Integrated Digital Intervention for Alcohol Use Disorder (NCT05748639) | Quit Genius | 2023-01-01 |
| Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease (NCT04094948) | Duke University | 2023-01-01 |
| Impact of Hemodialysis on Plasma Carnitine Levels in Patients With End Stage Renal Disease (NCT05817799) | Bahria University | 2023-01-01 |
| Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer (NCT06121700) | Fudan University | 2023-01-01 |
| Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome (NCT05599815) | Aldeyra Therapeutics, Inc. | 2023-01-01 |
| Dapaglifozin to Avoid Acute Kindey Injury (AKI) to Chronic Kidney Disease (CKD) Transition: DAKI-CKD Study (NCT05713851) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2023-01-01 |
| Hypomethylating Agent and Venetoclax After Allo-HSCT in Patients With High-risk Myeloid Malignancies. (NCT05841771) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2023-01-01 |
| Effect of Compound Kushen Injection Combined With Pabolizumab in the Treatment of Cervical Adenocarcinoma (NCT05259540) | Women's Hospital School Of Medicine Zhejiang University | 2023-01-01 |
| Ashwagandha for Cognitive Dysfunction (NCT04092647) | Sutter Health | 2023-01-01 |
| Evaluation of Safety and Efficacy of Wharton's Jelly Compared to Hyaluronic Acid and Saline for Knee Osteoarthritis. (NCT04711304) | BioIntegrate | 2023-01-01 |
| Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19 (NCT05142527) | Alachua Government Services, Inc. | 2023-01-01 |
| Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia (NCT03255408) | University of Calgary | 2023-01-01 |
| Effects of Ketosis on Muscle Kinetics and Signaling During Critical Illness. (NCT05074862) | Aarhus University Hospital | 2023-01-01 |
| Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcinoma (NCT06235918) | Xiang Lu | 2023-01-01 |
| Olive Leaf Extracts in the Control of Diabet (NCT05605704) | University of Monastir | 2023-01-01 |
| Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities (NCT05558501) | VA Office of Research and Development | 2023-01-01 |
| Ketamine for Multiple Sclerosis Fatigue (NCT05378100) | Johns Hopkins University | 2023-01-01 |
| HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy (NCT05300945) | Zhixin Cao | 2023-01-01 |
| Glutamate Inhibitors in Glioblastoma (NCT05664464) | University of Zurich | 2023-01-01 |
| Low Dose Decitabine in Combination With Tirelizumab Comparison of Tirelizumab in the First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma (NCT05638984) | Fudan University | 2023-01-01 |
| Study on the Efficacy and Toxicity of Pamiparib Combined With Tamoxifen in the Treatment of Epithelial Ovarian Cancer Patients With Biochemical Recurrence During First-line PARPi Maintenance Therapy (NCT05669768) | Sun Yat-sen University | 2023-01-01 |
| Probiotic and Antibiotic Therapies in Women With Unexplained Infertility (NCT04955574) | McMaster University | 2023-01-01 |
| Effect of Indication Based Blood Product Transfusion in Patients Undergoing Major Oncological Surgery (NCT05607940) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-01-01 |
| Valuation of the Safety and Efficacy of Combination of Cryoablation and Dendric Cell/Cytokine-induced Killers Cells Treatment for Advanced Liver Cancers (NCT05622825) | National Taiwan University Hospital | 2023-01-01 |
| Rh-PDGF vs EMD for Treatment of Intra-bony Defects (NCT05442034) | Nova Southeastern University | 2023-01-01 |
| Concentrated Complex Plant Dietary Elements for Chemotherapy-Induced Diarrhea (NCT07460596) | Tianjin Medical University Cancer Institute and Hospital | 2023-01-01 |
| Safety and Immunogenicity of the RNA MCTI CIMATEC HDT Vaccine (NCT05542693) | Azidus Brasil | 2023-01-01 |
| Evaluation of Different Orthodontic Tooth Movements Assisted With Injectable Platelet Rich Fibrin (NCT05616936) | Al-Azhar University | 2023-01-01 |
| IVIg Plus Low Dose rhTPO for ITP in Pregnancy (NCT05634824) | Peking University People's Hospital | 2023-01-01 |
| Efficacy of Low-dose PT-Cy for Prevention of GVHD in Ambulatory Allogeneic HSCT (NCT07319000) | Hospital Universitario Dr. Jose E. Gonzalez | 2023-01-01 |
| Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia (NCT05694962) | Jiangsu Cancer Institute & Hospital | 2023-01-01 |
| NEO- and Adjuvant Targeted Therapy in Braf-mutated Anaplastic Cancer of the Thyroid (NEO-ATACT Study) (NCT06079333) | Leiden University Medical Center | 2023-01-01 |
| AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING) (NCT05578430) | Sun Yat-sen University | 2023-01-01 |
| Evaluation of Conservative Management of Teeth With Deep Cavitated Carious Lesions (NCT06171776) | Cairo University | 2023-01-01 |
| The Rescue of Hormonal Replacement Frozen Embryo Transfer Cycle With Low Serum Progesterone. (NCT05758064) | El Shatby University Hospital for Obstetrics and Gynecology | 2023-01-01 |
| Androgen Reduction in Congenital Adrenal Hyperplasia (NCT03548246) | University of Texas Southwestern Medical Center | 2023-01-01 |
| Neoadjuvant Immunotherapy and Chemoradiotherapy for Locally Advanced Esophagogastric Junction Adenocarcinoma (NCT05505461) | Peking University People's Hospital | 2023-01-01 |
| Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder (NCT05554094) | Ohio State University | 2023-01-01 |
| Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes (NCT05608785) | Henan Cancer Hospital | 2023-01-01 |
| A Study of Ametumumab in Combination With Anti-PD-1 Monoclonal Antibody and FOLFIRI in Patients With RAS Wild-type Advanced Colorectal Cancer (NCT05684211) | Shanghai Celfuture Biotech Co., Ltd. | 2023-01-01 |
| Dapagliflozin in Pulmonary Arterial Hypertension (NCT05179356) | Mads Ersbøll | 2023-01-01 |
| Clinical Study of the Safety and Efficacy of the R/R B-NHL Regimen With BTK Inhibitor+Anti-CD19 CAR-T Cells (NCT05744037) | The Affiliated Hospital of Xuzhou Medical University | 2023-01-01 |
| Conversion Therapy of Disitamab Vedotin Combined With Sintilimab and S-1 in HER2 Overexpression Gastric Cancer (NCT05627414) | Tianjin Medical University Cancer Institute and Hospital | 2023-01-01 |
| Improving Beta-2 Adrenergic Signaling in Alzheimer's Disease (NCT02500784) | Palo Alto Veterans Institute for Research | 2023-01-01 |